Johan Lundin

  • PL 20 (Tukholmankatu 8)

    00014

    Finland

1994 …2022

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

Harri Sihto

Person: U3 Research and teaching staff

Johanna Arola

Person: U4 Research and teaching staff

Patrik Finne

Person: U4 Research and teaching staff

Mikko Mäyränpää

Person: U3 Research and teaching staff

Suvi Parviainen

Person: Visiting scholar

Harri Alenius

Person: Teaching and research personnel, U4 Research and teaching staff

Liisa Myllykangas, Associate professor

Person: U3 Research and teaching staff

Tiina Paunio

Person: UH, U4 Research and teaching staff

S Nordling

  • Univ Helsinki, Helsinki University Central Hospital, University of Helsinki, Dept Pathol, Cent Hosp, Jorvi Hosp

External person

Jorma Isola

  • University of Tampere
  • BioMediTech Finland

External person

Jorma Isola

  • Univ Tampere, University of Tampere, BioMediTech & FimLab Labs
  • University of Tampere
  • Univ Tampere, Tampere University, Tampere University Hospital, Tampere Univ Hosp, Fac Med & Hlth Technol, Allergy Ctr
  • Tampere Univ, Tampere University, Tampere University Hospital, Fac Med & Life Sci, Tampere Univ Hosp, Dept Surg

External person

K. von Boguslawski

  • University of Helsinki

External person

Taina Turpeenniemi-Hujanen

  • Oulu University Hospital

External person

Vinod Diwan

  • Karolinska Institutet

External person

Pirkko-Liisa Kellokumpu-Lehtinen

  • University of Tampere
  • Univ Tampere, Tampere University, Tampere University Hospital, Tampere Univ Hosp, Fac Med & Hlth Technol, Allergy Ctr
  • Tampere Univ Hosp, Tampere University, Tampere University Hospital, Dept Nephrol
  • Tampere Univ Hosp, Tampere University, Tampere University Hospital, Tays Canc Ctr, Ctr Res Dev & Innovat
  • Tampere Univ, Tampere University, Tampere Univ Lib
  • Tampere University Hospital (TAYS)
  • Univ Tampere, Tampere University, Tampere University Hospital, Tampere Univ Hosp, Fac Med & Life Sci, Dept Oncol
  • Tampere University Hospital

External person

M Victorzon

  • Kuopio University Hospital (KYS)

External person

Vesa Kataja

  • University of Eastern Finland (UEF)
  • Kuopio University Hospital (KYS)
  • Cent Finland Cent Hosp, Central Finland Central Hospital, Dept Obstet & Gynecol, Pelv Floor Res & Therapy Unit

External person

Clare Verrill

  • University of Oxford
  • Univ Southampton, University of Southampton, NIHR Oxford Biomed Res Ctr
  • NIHR Oxford Biomed Res Ctr, University of Oxford, Blood Theme

External person

Janusz Szymas

  • Poznan Univ Med Sci, Poznan University of Medical Sciences, Dept Clin Pathol

External person

Nina Linder

  • Uppsala Univ, Uppsala University, Dept Womens & Childrens Hlth, Int Maternal & Child Hlth

External person

Esa Rahtu

  • University of Oulu

External person

Stig Nordling

  • Univ Helsinki, Dept Pathol

External person

Hannu Moilanen

  • University of Oulu

External person

Slawomir Walkowski

  • Poznan Univ Tech, Poznan University of Technology

External person

Kristiina Iljin

  • VTT Technical Research Center of Finland
  • University of Turku

External person

Hannu Moilanen

  • University of Oulu

External person

Billy Ngasala

  • Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Med Entomol & Parasitol

External person

Aleksei Tiulpin

  • University of Oulu
  • University Hospital
  • Ailean Technologies Oy

External person

Lucie Laflamme

  • North West Univ, North West University - South Africa, Dept Phys
  • Karolinska Inst, Karolinska Institutet, ICMC

External person

Vinod Diwan

  • Karolinska Institutet

External person

Isaac Bogoch

  • University of Toronto
  • Univ Toronto, University of Toronto, University Health Network Toronto, Toronto General Hospital, Toronto Gen Hosp, Div Infect Dis

External person

Liisa Sailas

  • Kuopio University Hospital (KYS)

External person

Karl von Smitten

  • Eira Hosp Ltd
  • Eira Hospital

External person

J. Isola

  • University of Tampere

External person

Stig Nordling

  • Heart and Lung Centre HUCH and Helsinki University

External person

Vesa Kataja

  • Vaasa Cent Hosp
  • Central Finland Central Hospital

External person

Kalevi Kairemo

  • Docrates Canc Ctr

External person

R. Grenman

  • Univ Helsinki, Dept Pathol, Haartman Inst

External person

Matti Pietikainen

  • University of Oulu

External person

Jeffrey Shear

  • LLC–Ardsley

External person

Jan Trapman

  • Erasmus University Medical Center Rotterdam

External person

Kristiina Iljin

  • University of Turku

External person

Antti Vuolanto

  • Oncos Therapeutics Oy
  • Herantis Pharma Plc

External person

A. Mai

  • VTT Technical Research Center of Finland

External person

Hindrek Teder

  • Univ Tartu, University of Tartu, Inst Biomed & Translat Med, Dept Pathophysiol
  • University of Tartu
  • Univ Tartu, University of Tartu, Fac Med, Chair Med Microbiol & Virol, Inst Biomed & Translat Med
  • Univ Tartu, University of Tartu, Inst Biomed & Translat Med, Dept Pathophysiol, Fac Med

External person

Juhila Juuso

  • Oncos Therapeut Ltd

External person

Prerna Guleria

  • Delhi Cantt

External person

Carlos Castaneda-Orjuela

  • Inst Nacl Salud, Instituto Nacional de Salud (Colombia), Colombian Natl Hlth Observ
  • Instituto Nacional de Enfermedades Neoplásicas
  • Universidad Cientifica del Sur

External person

W El-Rifai

  • Univ Helsinki, Haartman Inst, Dept Med Genet

External person

Eduardo Richardet

  • Instituto Oncológico Córdoba

External person

Maud Olofsson

  • Univ Stellenbosch, Stellenbosch University, Wallenberg Res Ctr, Stellenbosch Inst Adv Study STIAS

External person

Maria Sundvall

  • Turku University Hospital
  • Univ Turku, University of Turku, Turku BioImaging

External person

Ferenc Kovacs

  • Single Cell Technol Ltd
  • Univ Helsinki, University of Helsinki, Inst Mol Med Finland FIMM
  • Single Cell Technol Ltd

External person

Masahito Yoshihara

  • Karolinska Inst, Karolinska Institutet, Dept Biosci & Nutr, Bioinformat & Express Anal Core Facil
  • Karolinska Institutet
  • Karolinska Inst, Karolinska Institutet, Dept Biosci & Nutr, NEO
  • Karolinska Institutet
  • Karolinska Inst, Karolinska Institutet, ICMC
  • Chiba Univ Hosp, Chiba University, Dept Otorhinolaryngol

External person

M. Jumppanen

  • University of Tampere

External person

Ilmari Ahonen

  • University of Turku

External person

Charlotta Backman

  • Oncos Therapeut

External person

T. Ranki

  • Oncos Therapeut

External person

Ani Orchanian-Cheff

  • Univ Hlth Network, University of Toronto, University Health Network Toronto, Hlth Sci Lib

External person

Aaltonen Kirsimari

  • Naistenklinikka
  • Syöpätautien osasto
  • Helsinki Univ Cent Hosp, Dept Obstet & Gynaecol
  • Univ Helsinki, Cent Hosp, Dept Oncol
  • Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol
  • Univ Helsinki, University of Helsinki, Dept Obstet & Gynecol
  • Univ Helsinki, Helsinki University Central Hospital, University of Helsinki, Cent Hosp, Dept Clin Genet
  • Univ Helsinki, University of Helsinki, Cent Hosp, Dept Oncol
  • Univ Helsinki, University of Helsinki; Lohja Hosp, Dept Obstet & Gynecol
  • Univ Helsinki, Helsinki University Central Hospital, University of Helsinki, Cent Hosp, Biomedicum Helsinki, Neurosurg Res Grp

External person

Mikael Mokkonen

  • University of Jyväskylä

External person

N. Allorto

  • Edendale Hosp, Dept Surg

External person

Paula Vainio

  • University of Turku

External person

Päivi P. Söderholm

  • Folkhalsan Res Ctr

External person

Marie Hasselberg

  • Univ Stellenbosch, Stellenbosch University, Wallenberg Res Ctr, Stellenbosch Inst Adv Study STIAS

External person

Hicham El Attar

  • Apc labs - Annasr Pathology Center

External person

Luz F. Sua

  • Universidad Icesi

External person

Peter J. Bostrom

  • University of Turku
  • Turku University Hospital

External person

Julian Fleming

  • Univ Stellenbosch, Stellenbosch University, Div Emergency Med

External person

Sami Varjo

  • University of Oulu

External person

Julia Karbach

  • Krankenhaus NW Frankfurt, Klin Onkol & Hamatol

External person

Pawan Kirtani

  • Manipal Hospitals

External person

Claudia Wahle

  • Krankenhaus NW Frankfurt, Hamatol Onkol

External person

S. Toikkanen

  • National Institute for Health and Welfare (THL)

External person

Magnus Jaderberg

  • Oncos Therapeutics Oy
  • Targovax ASA, Dept Clin Sci

External person

Johan Hansson

  • Karolinska University Hospital

External person

Petra W. van Duijn

  • Erasmus University Medical Center Rotterdam

External person

Laura Suoranta

  • Oncos Therapeut

External person

A. Vuolanto

  • Oncos Therapeut

External person

Joselyn Sanchez

  • Instituto Nacional de Enfermedades Neoplásicas

External person

K. Dienel

  • Oncos Therapeut

External person

Hans H Kreipe

  • Hannover Medical School

External person

Kaija Holli

  • Tampere University Hospital (TAYS)

External person

I. Chun Chen

  • National Taiwan University Hospital

External person

Daniel Sur

  • University of Medicine “I. Hatieganu”
  • Iuliu Hatieganu Univ Med & Pharm, Iuliu Hatieganu University of Medicine & Pharmacy, Allergol & Immunol Discipline

External person

Mika Hilvo

  • Zora Biosci

External person

Jack A. M. Fransen

  • Uppsala Univ, Uppsala University Hospital, Uppsala University, Univ Uppsala Hosp, Dept Med Sci, Gastroenterol & Hepatol Unit

External person

Seppo Pyrhonen

  • Turku University Hospital

External person

Matti Pietikäinen

  • University of Oulu

External person

Paulina Werner

  • Karolinska Inst, Karolinska Institutet, Inst Environm Med, Toxicol Unit
  • Karolinska Institutet

External person

Khalid El Bairi

  • Mohammed VI University Hospital

External person

K. Kairemo

  • Docrates Canc Ctr, Helsinki

External person

Catharina Barkman

  • Stockholm Cty Council, Stockholm City Council, Forum Hlth Policy

External person

Miluska Castillo

  • Instituto Nacional de Enfermedades Neoplásicas

External person

Jorma Isola

  • University of Tampere
  • Tampere University Hospital (TAYS)

External person

Elina Haavisto

  • Oncos Therapeutics Oy
  • University of Turku
  • Satakunta Hosp Dist

External person

Laura Lehtinen

  • VTT Technical Research Center of Finland
  • University of Turku

External person

Indu Arun

  • Tata Medical Center

External person

Marianne Lebbad

  • SMI, Swedish Inst Infect Dis Control

External person

Kaija Holli

  • Tampere University Hospital (TAYS)
  • University of Tampere

External person

Klaus Elenius

  • Turku University Hospital
  • Turku Univ Hosp, University of Turku, Div Med, Dept Nephrol
  • Turku Univ, University of Turku, Vaasa Central Hospital, Vaasa Cent Hosp, Dept Oncol

External person

Juha K. Rantala

  • VTT Technical Research Center of Finland
  • Misvik Biology Oy
  • Misvik Biol, Canc Res

External person

Kalle Alanen

  • Turku University Hospital

External person

Paivi Ostling

  • VTT Technical Research Center of Finland
  • Karolinska Institutet
  • Univ Helsinki, University of Helsinki, Inst Mol Med Finland, FIMM

External person

Karioja-Kallio Aila

  • Oncos Therapeut Ltd

External person

Kristiina Tyynela

  • Kuopio University Hospital (KYS)

External person

L. Vassilev

  • Oncos Therapeut

External person

M. von Euler

  • Oncos Therapeut

External person

Lee Wallis

  • Stellenbosch Univ, Div Emergency Med, Fac Med & Hlth Sci
  • Univ Stellenbosch, Stellenbosch University, Div Emergency Med
  • Univ Cape Town, University of Cape Town, Div Emergency Med

External person

Julia Karbach

  • Krankenhaus NW Frankfurt, Hamatol Onkol
  • Krankenhaus NW Frankfurt, Krankenhaus Nordwest, Dept Oncol & Hematol

External person

Peter Nyasulu

  • Univ Witwatersrand, University of Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Div Epidemiol & Biostat

External person

Veronica Bautista

  • Breast Cancer Center FUCAM

External person

Kari Syrjanen

  • Turku University Hospital

External person

P. Kovanen

  • HUCH, Dept Pathol

External person

Ravi Mehrotra

  • Natl Inst Canc Prevent & Res, Prevent Oncol
  • Natl Inst Canc Prevent & Res, Prevent Oncol Dept
  • Department of Health Research
  • India Canc Res Consortium
  • Indian Council Med Res, ICMR - Regional Medical Research Centre (RMRC), Bhubaneswar, Indian Council of Medical Research (ICMR), ICMR - National Institute of Traditional Medicine (NITM), Reg Med Res Ctr

External person

Timothy Onyuma

  • Kenyatta National Hospital

External person

Marie Hasselberg

  • Univ Stellenbosch, Stellenbosch University, Wallenberg Res Ctr, Stellenbosch Inst Adv Study STIAS

External person

F. Huss

  • Uppsala University
  • Uppsala Univ, Uppsala University Hospital, Uppsala University, Univ Uppsala Hosp, Dept Med Sci, Gastroenterol & Hepatol Unit

External person

Ewert Linder

  • University of Oulu

External person

J. Karbach

  • Krankenhaus NW Frankfurt, Hamatol Onkol

External person

Andreas Martensson

  • Uppsala Univ, Dept Womens & Childrens Hlth, IMCH

External person

Eunice Spengler

  • Hospital Universitario Austral

External person

Wentao Yang

  • Fudan Univ, Fudan University, Shanghai Canc Ctr, Dept Pathol
  • Fudan University Shanghai Cancer Center

External person

S. Tuomi

  • VTT Technical Research Center of Finland

External person

Farid Azmoudeh-Ardalan

  • Imam Khomeini Hospital

External person

Lotta Vassilev

  • University of Helsinki, Helsinki
  • Targovax Oy

External person

A. Viitanen

  • University of Tampere

External person

M L Larramendy

  • Univ Helsinki, Haartman Inst, Dept Med Genet

External person

Pirjo Pennanen

  • Vantaa Hlth Ctr
  • Hlth Ctr City Vantaa, Social & Hlth Bur City Vantaa
  • Prevent Healthcare, Welf Div, City Turku

External person

Paula Vainio

  • VTT Technical Research Center of Finland
  • University of Turku
  • Turku Univ Hosp, University of Turku, Hosp Dist South West Finland

External person

Guy Dumont

  • British Columbia Childrens Hosp, University of British Columbia, BC Childrens Hospital, Res Inst

External person

H. Syrjakari

  • Univ Helsinki, Mol Canc Biol Res Program, Inst Biomed

External person

Juuso Juhila

  • Oncos Therapeut

External person

M. Jaderberg

  • Oncos Therapeut

External person

Lotta Vassilev

  • Univ Helsinki, University of Helsinki, Dept Pathol, Fac Med, Canc Gene Therapy Grp

External person

Andrew Protheroe

  • University of Oxford
  • Oxford Univ Hosp NHS Fdn Trust, Oxford University Hospitals NHS Foundation Trust, Dept Oncol

External person

Kasper Dienel

  • Oncos Therapeutics Oy

External person

J. Nevo

  • VTT Technical Research Center of Finland

External person

Amine Kallala

  • Hopital Charles Nicolle

External person

Juliana Ribeiro de Freitas

  • Medical School of the Federal University of Bahia

External person

M. Pietikainen

  • Univ Helsinki

External person

Bernardo L. Rapoport

  • The Medical Oncology Centre of Rosebank
  • Faculty of Health Sciences

External person

Constance Boissin

  • Karolinska Institutet
  • Karolinska Inst, Karolinska Institutet, ICMC

External person

T. Turpeenniemi-Hujanen

  • University of Oulu

External person

Ewert Linder

  • SMI, Swedish Inst Infect Dis Control

External person

R. Heikkila

  • Univ Helsinki, Cent Hosp, Dept Pathol

External person

Mikael von Euler

  • Oncos Therapeutics Oy

External person

K Elenius

  • University of Turku

External person

Claudia Wahle

  • Krankenhaus NW Frankfurt, Klin Onkol & Hamatol

External person

Gabriela Acosta-Haab

  • Hospital de Oncología Maria Curie

External person

Lotta Vassilev

  • Oncos Therapeutics Oy

External person

L Wallis

  • Australian and New Zealand Intensive Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
  • Univ Cape Town, University of Cape Town

External person

Marianne Lebbad

  • Swedish Inst Communicable Dis Control SMI

External person

P. Popov

  • HUCH, Dept Plast Surg
  • Eira Hosp Ltd

External person

Petri Priha

  • Oncos Therapeutics Oy
  • Valo Therapeut Ltd

External person

Masoumeh Gharib

  • Mashhad University of Medical Sciences, School of Medicine

External person

K. Holli

  • Univ Helsinki, Cent Hosp, Dept Oncol

External person

Antti Vuolanto

  • TKK
  • Targovax Oy

External person

Jenny C. Taylor

  • NIHR Oxford Biomed Res Ctr, University of Oxford, Blood Theme
  • University of Oxford

External person

Isabel Frahm

  • Sanatorio Mater Dei

External person

Lukas Wisgrill

  • Med Univ Vienna, Medical University of Vienna, Comprehens Ctr Pediat, Div Neonatol Pediat Intens Care & Neuropediat
  • Karolinska Inst, Karolinska Institutet, Inst Environm Med, Toxicol Unit
  • Med Univ Vienna, Medical University of Vienna, Dept Pediat, Div Neonatol Pediat Intens Care & Neuropediat
  • Karolinska Institutet
  • Medical University of Vienna
  • Karolinska Inst, Karolinska Institutet, Inst Environm Med, Unit Epidmiol

External person

Meri-Sisko Vuoristo

  • Tampere University Hospital (TAYS)

External person

A. Ribeiro

  • FIMM, Inst Mol Med Finland

External person

Marjut Laukka

  • Univ Helsinki, Cent Hosp, Dept Radiol

External person

Elke Jaeger

  • Krankenhaus NW Frankfurt, Klin Onkol & Hamatol

External person

Edith A. Perez

  • Mayo Clinic
  • Mayo Clinic in Jacksonville, Florida

External person

Alon Vaisman

  • Univ Toronto, University of Toronto, University Health Network Toronto, Toronto General Hospital, Toronto Gen Hosp, Div Infect Dis

External person

Ulrika Stierner

  • Sahlgrens Univ Hosp, Dept Oncol

External person

K. Partanen

  • Docrates Canc Ctr, Helsinki

External person

Sophia Turner

  • Independent Cancer Patient Voice

External person

T. Lehtimaki

  • Univ Helsinki, Cent Hosp, Dept Oncol

External person

Marcelo Balancin

  • Universidade de São Paulo

External person

Harri Visapää

  • Univ Helsinki, Cent Hosp, Dept Urol

External person

C. Backman

  • Oncos Therapeut

External person

Tuulikki Seppanen-Laakso

  • VTT Technical Research Center of Finland

External person

Reena R. Md Zin

  • UKM Medical Centre

External person

Jean T. Coulibal

  • Univ Felix Houphouet Boigny, Unite Format & Rech Biosci

External person

Edward Alveyn

  • Oxford Brookes University

External person

Cecilia Thors

  • SMI, Swedish Inst Infect Dis Control

External person

Lucie Laflamme

  • Univ South Africa, University of South Africa, Inst Social & Hlth Sci

External person

V. Kataja

  • Kuopio University Hospital (KYS)

External person

Erik Iwarsson

  • Karolinska University Hospital

External person

Pekka Kohonen

  • VTT Technical Research Center of Finland
  • VTT Tech Res Ctr Finland, VTT Technical Research Center Finland, VTT Hlth
  • Dept Toxicol, Misvik Biol

External person

Dmitrii Byckhov

  • Univ Helsinki, University of Helsinki, Inst Mol Med Finland FIMM

External person

Kristiina Aalto-Korte

  • Finnish Inst Occupat Hlth, Finnish Institute of Occupational Health, Occcupat Med

External person

Tuuli Ranki

  • Targovax Oy
  • ValoTherapeut
  • Valo Therapeut Ltd

External person

M Tanner

  • Tampere Univ, Tampere University, Tampere University Hospital, Fac Med & Life Sci, Tampere Univ Hosp, Dept Surg

External person

Christina Leslie

  • Mem Sloan Kettering Canc Ctr, Memorial Sloan Kettering Cancer Center, Sloan Kettering Inst, Computat & Syst Biol Program

External person

S. Walkowski

  • Faculty of Computing, Poznan University of Technology

External person

Pia Vihinen

  • Turku University Hospital
  • Turku Univ, University of Turku, Cent Hosp, FICAN West Canc Ctr
  • Turku Univ, University of Turku, Vaasa Central Hospital, Vaasa Cent Hosp, Dept Oncol
  • Univ Turku, University of Turku, Clin Neurosci, Dept Neurosurg, Turku Brain Injury Ctr,Turku Univ Hosp

External person

Tuomo Alanko

  • Docrates Canc Ctr, Helsinki

External person

Richard Colling

  • Oxford Univ Hosp NHS Fdn Trust, Oxford University Hospitals NHS Foundation Trust, Dept Cellular Pathol
  • University of Oxford
  • University of Oxford Medical Sciences Division
  • Oxford University Hospitals NHS Foundation Trust

External person

Elizabeth Blackley

  • Peter Maccallum Cancer Centre

External person

Luis Claudio Amendola

  • Brazilian Society of Oncology

External person

Johnson Joseph

  • Oxford Univ Hosp NHS Fdn Trust, Oxford University Hospitals NHS Foundation Trust, Dept Oncol

External person

Petri Priha

  • Helsinki University of Technology

External person

T Huhta

  • Univ Helsinki, Haartman Inst, Dept Med Genet

External person

Tiina Skoog

  • Karolinska Institutet
  • Karolinska Inst, Karolinska Institutet, Dept Biosci & Nutr, Bioinformat & Express Anal Core Facil
  • Karolinska Inst, Karolinska Institutet, Dept Biosci & Nutr, NEO

External person

Theo van der Kwast

  • Princess Margaret Canc Ctr, University of Toronto, Princess Margaret Cancer Centre, University Health Network Toronto, Div Epidemiol

External person

Richard K. D. Ephraim

  • Univ Cape Coast, University of Cape Coast, Dept Med Lab Sci

External person

Andreas Martensson

  • Karolinska Institutet

External person

Wolfgang Sommergruber

  • Boehringer Ingelheim RCV GmbH & Co KG, Boehringer Ingelheim, Dept Lead Discovery

External person

E. Jaeger

  • Krankenhaus NW Frankfurt, Hamatol Onkol
  • GSI Helmholtz Ctr Heavy Ion Res, GSI Helmholtz-Center for Heavy Ion Research, Helmholtz Association

External person

Elke Jaeger

  • Krankenhaus NW Frankfurt, Hamatol Onkol

External person

Katja Välimäki

  • Suomen Molekyylilääketieteen Insitituutti, FIMM, Helsingin Yliopisto

External person

Magnus Jaderberg

  • Oncos Therapeut
  • Targovax ASA, Dept Clin Sci

External person

Harry R. Haynes

  • Great Western Hospital
  • MRC Integrative Epidemiology Unit at the University of Bristol

External person

Liisa Sailas

  • University of Turku
  • North Carelia Cent Hosp, Dept Urol

External person

Ellika Sahlin

  • Karolinska Institutet
  • Karolinska University Hospital

External person

Lars Bastholt

  • Odense Univ Hosp, Dept Oncol

External person

Pekka Taimen

  • University of Turku
  • Turku University Hospital

External person

Paula Gonzalez Ericsson

  • Vanderbilt Univ, Vanderbilt University
  • Vanderbilt-Ingram Cancer Center

External person

Dirk M. Nettelbeck

  • German Canc Res Ctr, German Cancer Research Center, Helmholtz Association

External person

Susan Fineberg

  • Albert Einstein College of Medicine of Yeshiva University

External person

Najat Bouchmaa

  • Mohammed VI Polytechnic University
  • Sultan Moulay Slimane Univ, Sultan Moulay Slimane University of Beni Mellal, Fac Sci & Technol, Team Cellular & Mol Immunopharmacol, Lab Biol Engn,Nat Susbst,Immunobiol Canc Cells

External person

Mahmoud Abbas

  • The Institute for Molecular Medicine Finland (FIMM)

External person

Tiina Hakonen

  • Oncos Therapeutics Oy

External person

Friedrich Feuerhake

  • Hannover Medical School

External person

J. Szymas

  • Univ Med Sci, Dept Clin Pathol

External person

J. Ivaska

  • University of Turku

External person

Juuso Juhila

  • Oy Medix Biochemica Ab
  • Actim Oy

External person

An Coosemans

  • UZ Leuven, KU Leuven, University Hospital Leuven, Abdominale Transplantatiechirurg
  • KU Leuven

External person

Johann Groenewald

  • Univ Stellenbosch, Stellenbosch University, Wallenberg Res Ctr, Stellenbosch Inst Adv Study STIAS

External person

Ewert Linder

  • Karolinska Institutet

External person

Lars Weinehall

  • Umea Univ Hosp, Umea University, Dept Publ Hlth & Clin Med

External person

Byron Leiva

  • Natl Univ Leon, UNAN, Dept Microbiol

External person

Seppo Pyrhonen

  • University of Turku

External person

Mari Björkman

  • VTT Technical Research Center of Finland

External person

Laura Lehtinen

  • Turku City Hospital

External person

C. Wahle

  • Krankenhaus NW Frankfurt, Hamatol Onkol

External person

S. Pesonen

  • Oncos Therapeut

External person

Karin Pettersson

  • Karolinska Univ Hosp, Karolinska Institutet, Karolinska University Hospital, Theme Neuro

External person

J. Juhila

  • Oncos Therapeut

External person

Taina Turpeenniemi-Hujanen

  • University of Oulu, Oulu
  • University of Oulu
  • Oulu Univ Hosp, University of Oulu, MRC Med Reasearch Ctr, Dept Oncol & Radiotherapy
  • Univ Oulu, University of Oulu, Kajaani Univ Consortium, CEMIS OULU
  • Univ Oulu, University of Oulu, Div Intens Care Med, Fac Med, Oulu Univ Hosp,Med Res Ctr Oulu,Res Grp Surg Anes
  • Oulu Univ Hosp, University of Oulu, Endocrinol

External person

P. Priha

  • Oncos Therapeut

External person

Zaheed Husain

  • Praava Health

External person

E. Haavisto

  • Oncos Therapeut
  • University of Turku

External person

Emad Shash

  • Cairo University

External person

Kaija Holli

  • University of Tampere

External person

Johannes Virtanen

  • VTT Technical Research Center of Finland
  • University of Turku

External person

Charlotta Backman

  • Oncos Therapeutics Oy

External person

Timo Ahonen

  • University of Oulu
  • Univ Jyvaskyla, University of Jyvaskyla, Dept Psychol, Ctr Res Learning & Teaching

External person

O. T. Pentikainen

  • University of Jyväskylä

External person

T. Hakonen

  • Oncos Therapeut

External person

Jari Hannuksela

  • University of Oulu

External person

Lee A. Wallis

  • Univ Stellenbosch, Stellenbosch University, Div Emergency Med

External person

Jose Fernando Do Prado Moura

  • Centro de Pesquisas Clinicas do IMIP

External person

H. Keski-Säntti

  • Univ Helsinki, Cent Hosp, Dept Otolaryngol Head & Neck Surg

External person

Luciana Fujimoto

  • Amazon Federal University

External person

Peter de Wilde

  • Tufts Univ, Tufts University, United States Department of Agriculture (USDA), Friedman Sch Nutr Sci & Policy, Jean Mayer USDA Human Nutr Res Ctr Aging

External person

Shi Wei Liu

  • Sichuan Cancer Hospital and Institute

External person

Steinar Aamdal

  • Oslo University Hospital

External person

Mika Hilvo

  • VTT Technical Research Center of Finland

External person

T. Alanko

  • Docrates Canc Ctr, Helsinki

External person

Ruohong Shui

  • Fudan University Shanghai Cancer Center

External person

Shintaro Katayama

  • Karolinska Institutet
  • Karolinska Inst, Karolinska Institutet, Dept Biosci & Nutr, Bioinformat & Express Anal Core Facil

External person

Pia P. Vihinen

  • Turku University Hospital

External person

Jorma Isola

  • Univ Helsinki, Mol Oncol Lab, Biomedicum Helsinki

External person

Wenxian Yang

  • Aginome Scientific

External person

Johanna Ivaska

  • University of Turku
  • VTT Technical Research Center of Finland

External person

Petra Maki-Teeri

  • Univ Helsinki, University of Helsinki, Inst Mol Med Finland FIMM

External person

Kaarina Partanen

  • Docrates Canc Ctr

External person

Heikki Seikkula

  • Cent Hosp Cent Finland, Central Finland Central Hospital, Dept Gastrointerstinal Surg

External person

Robert Pell

  • Oxford Univ Hosp NHS Fdn Trust, Oxford University Hospitals NHS Foundation Trust, Dept Cellular Pathol

External person

F. Zhang

  • Central China Normal University

External person

Guy Dumont

  • Univ Stellenbosch, Stellenbosch University, Wallenberg Res Ctr, Stellenbosch Inst Adv Study STIAS

External person

Timo Joensuu

  • Docrates Canc Hosp

External person

Jadwiga Winiecka-Krusnell

  • SMI, Swedish Inst Infect Dis Control

External person

Eeva Martelin

  • Univ Helsinki, University of Helsinki, Childrens Hosp; Univ Helsinki, University of Helsinki, Jorvi Hosp; Univ Helsinki, Helsinki University Central Hospital, University of Helsinki, Cent Hosp

External person

P. Gustafson

  • University of Lund

External person

F. Biancari

  • Oulu University Hospital

External person

Karen Willard-Gallo

  • Institut Jules Bordet

External person

Elena Provenzano

  • Addenbrookes Hospital - Cambridge University Hospitals
  • Cambridge University Hospitals NHS Foundation Trust

External person

Huang Chun Lien

  • National Taiwan University Hospital

External person

Sean Broomhead

  • Hlth Informat Syst Programme

External person